Synapse - Works

Results (82)

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Journal Article

Leiding, J. W.; Arnold, D. E.; Parikh, S.; Logan, B.; Marsh, R. A.; Griffith, L. M.; Wu, R.; Kidd, S.; Mallhi, K.; Chellapandian, D.; more...
Blood (2023)

Fulltext@MSK | Save

Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant

Journal Article

Miltiadous, O.; Waters, N. R.; Andrlová, H.; Dai, A.; Nguyen, C. L.; Burgos da Silva, M.; Lindner, S.; Slingerland, J.; Giardina, P.; Clurman, A.; more...
Blood (2022)

Fulltext@MSK | Save

Overall survival by best overall response with tabelecleucel in patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease following solid organ or allogeneic hematopoietic cell transplant

Meeting Abstract

Prockop, S.; Gamelin, L.; Dinavahi, R.; Sun, Y.; Zhao, W. Z.; Galderisi, F.; Mehta, A.
Blood (2021)

Fulltext@MSK | Save

Multicenter, open-label, phase 3 study of tabelecleucel for solid organ or allogeneic hematopoietic cell transplant recipients with Epstein-Barr virus-driven post transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE)

Meeting Abstract

Prockop, S.; Mahadeo, K. M.; Beitinjaneh, A.; Choquet, S.; Stiff, P.; Reshef, R.; Satyanarayana, G.; Dahiya, S.; Parmar, H.; Ye, W.; more...
Blood (2021)

Fulltext@MSK | Save

Interim results of a pilot, prospective, randomized, double-blinded, vehicle- and comparator-controlled trial on safety and efficacy of a topical inhibitor of janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non- sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease

Meeting Abstract

Markova, A.; Pan, A.; Dusza, S.; Chowdhury, A.; Kukoyi, O.; Perales, M. A.; Lacouture, M.; Prockop, S.; Ponce, D. M.
Blood (2021)

Fulltext@MSK | Save

JSP191 As a single-agent conditioning regimen results in successful engraftment, donor myeloid chimerism, and production of donor derived naive lymphocytes in patients with severe combined immunodeficiency (SCID)

Meeting Abstract

Agarwa, R.; Dvorak, C. C.; Prockop, S.; Kwon, H. S.; Long-Boyle, J. R.; Le, A.; Brown, J. W.; Merkel, E.; Truong, K.; Velasco, B.; more...
Blood (2021)

Fulltext@MSK | Save

CD4(+) T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: A dual-center validation

Journal Article

de Koning, C.; Prockop, S.; van Roessel, I.; Kernan, N.; Klein, E.; Langenhorst, J.; Szanto, C.; Belderbos, M.; Bierings, M.; Boulad, F.; more...
Blood (2021)

Fulltext@MSK | Save

Clinical experience of tabelecleucel in patients with life-threatening complications of Epstein-Barr virus viremia

Meeting Abstract

Torno, L.; Dahlberg, A.; Ghobadi, A.; Stiff, P.; Reshef, R.; Weng, W. K.; Navarro, W.; Gamelin, L.; Dinavahi, R.; Sun, Y.; more...
Blood (2020)

Fulltext@MSK | Save

A Multicenter, multicohort, open-label, single-arm per cohort, phase II study to assess the efficacy and safety of tabelecleucel in patients with EBV-associated diseases using an adaptive two-stage study design

Meeting Abstract

Prockop, S.; Dinavahi, R.; Navarro, W.; Guzman-Becerra, N.; Sun, Y.; Gamelin, L.
Blood (2020)

Fulltext@MSK | Save

Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults

Meeting Abstract

Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
Blood (2020)

Fulltext@MSK | Save